Brickell Biotech Inc (NASDAQ:BBI)
| 2.93 Delayed Data As of 3:59pm ET |  +0.36 / +14.01%Today’s Change | 1.05 Today|||52-Week Range 8.96 | +95.33% Year-to-Date |
Latest BBI News | Press Releases
No recent news for Brickell Biotech Inc.
Today’s Trading
| Previous close | 2.57 |
| Today’s open | 2.57 |
| Day’s range | 2.25 - 2.93 |
| Volume | 212,785 |
| Average volume (3 months) | 573,666 |
| Market cap | $23.6M |
Data as of 3:59pm ET, 02/28/2020
Growth & Valuation
| Earnings growth (last year) | +26.32% |
| Earnings growth (this year) | +48.65% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -88.26% |
| P/E ratio | NM |
| Price/Sales | 15.89 |
| Price/Book | 0.19 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SBPHSpring Bank Pharmace... | +0.04 | +2.66% |
| VVUSVivus Inc | -0.06 | -3.21% |
| CLRBCellectar Bioscience... | -0.07 | -3.21% |
| IMRNImmuron Ltd | -1.25 | -27.78% |
Data as of 3:59pm ET, 02/28/2020
Financials
| Next reporting date | March 11, 2020 |
| EPS forecast (this quarter) | $0.00 |
| Annual revenue (last year) | $1.6M |
| Annual profit (last year) | -$16.3M |
| Net profit margin | -1,002.10% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
